1.Fluoroscopy-Guided Endovenous Sclerotherapy Using a Microcatheter Prior to Endovenous Laser Ablation: Comparison between Liquid and Foam Sclerotherapy for Varicose Tributaries.
Sang Woo PARK ; Ik Jin YUN ; Jae Joon HWANG ; Song Am LEE ; Jun Seok KIM ; Hyun Keun CHEE ; Il Soo CHANG
Korean Journal of Radiology 2014;15(4):481-487
OBJECTIVE: To compare the efficacy and adverse effects of endovenous foam sclerotherapy (EFS) and liquid sclerotherapy (ELS) using a microcatheter for the treatment of varicose tributaries. MATERIALS AND METHODS: From December 2007 to January 2009, patients with venous reflux in the saphenous vein were enrolled. The foam or liquid sclerosant was injected through a microcatheter just before endovenous laser ablation (EVLA). Patients were evaluated for the technical success, clinical success, and procedure-related complications during the procedure and follow-up visits. RESULTS: A total of 94 limbs were included: 48 limbs (great saphenous vein [GSV], 35; small saphenous vein [SSV], 13) were managed using EFS and EVLA (foam group; FG), and 46 limbs (GSV, 37; SSV, 9) were treated by ELS and EVLA (liquid group; LG). Varicose tributaries demonstrated complete sclerosis in 92.7% with FG and in 71.8% with LG (p = 0.014). Bruising (78.7% in FG vs. 73.2% in LG, p > 0.05), pain or tenderness (75.6% in FG vs. 51.2% in LG, p = 0.0237) were noted. Hyperpigmentation (51.2% in FG vs. 46.2% in LG, p > 0.05) was found. CONCLUSION: Endovenous foam sclerotherapy using a microcatheter is more effective than ELS for eliminating remnant varicose tributaries prior to EVLA. However, EFS is more commonly associated with local complications such as pain or tenderness than ELS. Furthermore, both techniques seem to prolong the duration of hyperpigmentation along with higher costs.
Catheters/adverse effects
;
Femoral Vein
;
Fluoroscopy/methods
;
Humans
;
Laser Therapy/methods
;
Radiography, Interventional/methods
;
*Saphenous Vein/radiography/surgery
;
Sclerosing Solutions/*administration & dosage/chemistry
;
Sclerotherapy/adverse effects/instrumentation/*methods
;
Treatment Outcome
;
Varicose Veins/radiography/*therapy
;
Venous Insufficiency/surgery
2.One day surgery in the treatment of benign prostatic enlargement with thulium laser: A single institution experience.
Luca CARMIGNANI ; Alberto MACCHI ; Dario RATTI ; Elisabetta FINKELBERG ; Stefano CASELLATO ; Serena MARUCCIA ; Carlo MARENGHI ; Stefano Carlo Maria PICOZZI
Korean Journal of Urology 2015;56(5):365-369
PURPOSE: Various articles have previously addressed the introduction of new surgical laser therapies for an enlarged prostate gland causing obstructive symptoms. The objective of this study was to report the feasibility of performing the thulium laser vapo-enucleation of the prostate (ThuVEP) procedure for benign prostatic obstruction in a 1-day surgery. MATERIALS AND METHODS: From September 2011 to September 2013, we conducted a prospective study on patients who underwent ThuVEP in a 1-day surgery. The primary outcomes measured perioperatively included operative time, resected tissue weight, hemoglobin decrease, transfusion rate, postoperative irrigation and catheterization time, and postoperative hospital stay. Also, the preoperative and postoperative International Prostate Symptom Score (IPSS) and results of uroflowmetry performed on the 7th and 30th postoperative days were recorded. All perioperative and postoperative complications were monitored. RESULTS: A total of 53 patients underwent the surgical treatment in a 1-day surgery. Seven patients continued antiaggregant therapy with aspirin. Mean preoperative prostatic adenoma volume was 56.6 mL. Mean operative time was 71 minutes. The average catheter time was 14.8 hours. The peak urinary flow rate on day 7 improved from 9.3 to 17.42 mL/s (p<0.001) and the IPSS improved from 18 to 10.2 (p<0.01). Patients were routinely discharged on the day of catheter removal. No complications were recorded. CONCLUSIONS: ThuVEP can be safely conducted as a 1-day surgical procedure. This strategy results in cost savings. ThuVEP shows good standardized outcomes with respect to improvement in flow parameters and length of bladder catheterization.
Aged
;
Ambulatory Surgical Procedures
;
Humans
;
Laser Therapy/adverse effects/*instrumentation
;
Lasers, Solid-State/*therapeutic use
;
Length of Stay
;
Male
;
Middle Aged
;
Operative Time
;
Prospective Studies
;
Prostate/*surgery
;
Prostatic Hyperplasia/*surgery
;
Thulium/*therapeutic use
;
Transurethral Resection of Prostate
;
Treatment Outcome